Highline Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8K | Buy |
144
+17
| +13% | +$3.16K | 0.01% | 182 |
|
|
2025
Q1 | $26.5K | Buy |
127
+51
| +67% | +$10.7K | 0.01% | 171 |
|
|
2024
Q4 | $13.5K | Sell |
76
-5
| -6% | -$888 | ﹤0.01% | 211 |
|
|
2024
Q3 | $16.1K | Buy |
81
+6
| +8% | +$1.19K | 0.01% | 205 |
|
|
2024
Q2 | $12.9K | Buy |
75
+6
| +9% | +$1.03K | ﹤0.01% | 198 |
|
|
2024
Q1 | $12.6K | Hold |
69
| – | – | 0.01% | 208 |
|
|
2023
Q4 | $10.7K | Sell |
69
-49
| -42% | -$7.59K | 0.01% | 200 |
|
|
2023
Q3 | $17.6K | Buy |
118
+49
| +71% | +$7.3K | 0.01% | 156 |
|
|
2023
Q2 | $9.3K | Sell |
69
-10
| -13% | -$1.35K | 0.01% | 160 |
|
|
2023
Q1 | $12.6K | Buy |
79
+3
| +4% | +$478 | 0.01% | 153 |
|
|
2022
Q4 | $12.3K | Hold |
76
| – | – | 0.01% | 150 |
|
|
2022
Q3 | $10.2K | Buy |
+76
| New | +$10.2K | 0.01% | 140 |
|